We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Cephalon's Provigil Receives Pediatric Exclusivity
The FDA has granted six months of pediatric exclusivity for Cephalon’s narcolepsy drug Provigil, a move that could delay generic competition on the drug until 2012.